HTX1002
This study is assessing a therapeutic HIV vaccine as an alternative treatment for people living with HIV. This trial completed enrollment in January 2020 and is ongoing.
This author has not written his bio yet.
But we are proud to say that Academic Web Pages contributed 97 entries already.
This study is assessing a therapeutic HIV vaccine as an alternative treatment for people living with HIV. This trial completed enrollment in January 2020 and is ongoing.
Members of CVVR joined Team BIDMC for the 2019 Boston Pride Parade.
Members of the CVVR joined TEAM BIDMC for the 2019 Aids Walk, which is the largest HIV/AIDS awareness event in New England.
Dr. Dan Barouch accepts the Best Academic Research Team, Vaccine Industry Excellence Award, World Vaccine Congress 2019 in Washington D.C., on April 15th 2019
“The annual Conference on Retroviruses and Opportunistic Infections (CROI) brings together top basic, translational, and clinical researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases. CROI 2019 will be held from March 4 to March 7, 2019, at the Washington State Convention Center in Seattle, Washington.”
Dr. Dan Barouch discusses the challenges in designing an HIV vaccine and the ongoing clinical trials with vaccine research at BIDMC.
[Podcast]
2018 Reeve’s Annual Winter Employee Event
3 Blackfan Circle
Boston, MA 02115 – USA
T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu
T 617.735.4610
E CVVRtrials@bidmc.harvard.edu